Published Online:
July 6, 2011
This is the protocol for a review and there is no abstract. The objectives are as follows:
To examine the benefits (less severe AEs and improved HRQoL and adherence) and harms (more severe AEs, decreased HRQoL, and treatment discontinuation) of interventions (including patient education and pharmacological agents) for the treatment of people who experience selected skin AEs due to targeted anticancer treatment.